Cogent Biosciences, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
COGT on Nasdaq
Location
275 Wyman Street, 3 Rd Floor, Waltham, MA

There are no Buy or Sell transactions made by insiders since 9/18/2023

Cogent Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fairmount Funds Management LLC Director $46.7M Jun 10, 2024
Andrew R. Robbins President and CEO, Director $7.9M Jan 23, 2024
Cole Pinnow Chief Commercial Officer $3.78M May 25, 2024
John L. Green Chief Financial Officer $2.16M Jan 23, 2024
John Edward Robinson Chief Scientific Officer $2.16M Jan 23, 2024
Jessica Sachs Chief Medical Officer $2.16M Jan 23, 2024
Evan Kearns Chief Legal Officer $1.83M Jan 23, 2024
Todd Shegog Director $321K Jun 5, 2024
Matthew Ros Director $321K Jun 5, 2024
Christopher W. Cain Director $321K Jun 5, 2024
Peter Evan Harwin Director $321K Jun 5, 2024
Arlene Morris Director $321K Jun 5, 2024
Karen Jean Ferrante Director $17.7K Jul 1, 2024

Recent Insider Transactions by Companies or Individuals for Cogent Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.